SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001213900-21-001516
Filing Date
2021-01-12
Accepted
2021-01-11 17:42:25
Documents
38

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO FORM S-4 fs42021a3_fsdevelopment.htm S-4/A 14267380
2 CONSENT OF WITHUMSMITH+BROWN, PC, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM fs42021a3ex23-1_fsdevelop.htm EX-23.1 2207
3 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF G fs42021a3ex23-2_fsdevelop.htm EX-23.2 1761
4 GRAPHIC timage_001.jpg GRAPHIC 254775
  Complete submission text file 0001213900-21-001516.txt   16583457

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE fsdc-20200930.xml EX-101.INS 322749
6 XBRL SCHEMA FILE fsdc-20200930.xsd EX-101.SCH 32526
7 XBRL CALCULATION FILE fsdc-20200930_cal.xml EX-101.CAL 19681
8 XBRL DEFINITION FILE fsdc-20200930_def.xml EX-101.DEF 149186
9 XBRL LABEL FILE fsdc-20200930_lab.xml EX-101.LAB 256294
10 XBRL PRESENTATION FILE fsdc-20200930_pre.xml EX-101.PRE 154105
Mailing Address C/O FORESITE CAPITAL, 600 MONTGOMERY ST SUITE 4500 SAN FRANCISCO CA 94111
Business Address C/O FORESITE CAPITAL, 600 MONTGOMERY ST SUITE 4500 SAN FRANCISCO CA 94111 (415) 877-4887
FS Development Corp. (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-249785 | Film No.: 21521814
SIC: 2834 Pharmaceutical Preparations